Cytodyn Inc (CYDY)

[Saltz]

Grip, the level of financial resources being diverted to COVID-19 is minimal and inconsequential in terms of compromising the BLA.

The MOA is scientifically compelling enough to give Leronlimab an opportunity to save lives. The level of efficacy or actual economic gain for CYDY is a gamble but a responsibility proven by the decision of the overseeing physician in selecting Leronlimab over alternate drugs.

The talk that Nader is just trying to blindly pump Leronlimab in the COVID-19 space is another telegraphed play by those that are already vehemently bashing CYDY.

If I believed this was just another fluff PR strategy I would not be invested. There is no sense in knowingly going down a path that is a dead end. I’m of the mind to see what happens with these very sick patients - good for Nader for having the guts to take on the risk.